Education
About Us
Working with TipRanks
Follow Us
MedCap AB (DE:61MA)
FRANKFURT:61MA
61MA Stock Chart & Stats
Day’s Range― - ―
52-Week Range€29.40 - €59.40
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€879.12M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)49.1
Beta<0.01
Next Earnings
Oct 24, 2025EPS Estimate
0.3Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.32
Shares Outstanding15,044,353
10 Day Avg. Volume1
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€42.86Price Target Upside-26.10% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering0
MedCap AB News
61MA FAQ
What was MedCap AB’s price range in the past 12 months?
MedCap AB lowest stock price was €29.40 and its highest was €59.40 in the past 12 months.
What is MedCap AB’s market cap?
MedCap AB’s market cap is €879.12M.
When is MedCap AB’s upcoming earnings report date?
MedCap AB’s upcoming earnings report date is Oct 24, 2025 which is in 82 days.
How were MedCap AB’s earnings last quarter?
MedCap AB released its earnings results on Jul 23, 2025. The company reported €0.323 earnings per share for the quarter, the consensus estimate of €0.323 by €0.
Is MedCap AB overvalued?
According to Wall Street analysts MedCap AB’s price is currently Overvalued.
Does MedCap AB pay dividends?
MedCap AB does not currently pay dividends.
What is MedCap AB’s EPS estimate?
MedCap AB’s EPS estimate is 0.3.
How many shares outstanding does MedCap AB have?
MedCap AB has 15,044,353 shares outstanding.
What happened to MedCap AB’s price movement after its last earnings report?
MedCap AB reported an EPS of €0.323 in its last earnings report, expectations of €0.323. Following the earnings report the stock price went down -0.957%.
Which hedge fund is a major shareholder of MedCap AB?
Currently, no hedge funds are holding shares in DE:61MA
Company Description
MedCap AB
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, and pharmaceuticals companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Northern Europe. It typically invests between SEK25 million ($2.75 million) to SEK150 million ($16.51 million) with enterprise value and sales revenue between SEK50 million ($5.90 million) to SEK200 million ($23.06 million) and EBITDA between SEK1 million ($0.11 million) to SEK50 million ($5.50 million). The firm seeks to acquire stakes between 20% and 50% in its portfolio companies. It uses its capital and loans and makes balance sheet investments. MedCap AB (publ) was founded in 2001 and is based in Stockholm, Sweden.
Technical Analysis
Idun Industrier AB Class B
―
Bure Equity AB
―
Vo2 Cap Holding AB
―
Linc AB
―
Svolder AB Class B
―
Ownership Overview
―
Insiders
0.33%
Mutual Funds
― Other Institutional Investors
99.40% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---